Pharmacoeconomic review of the use of injectable long-acting risperidone;A tartós hatású risperidon injekció alkalmazásának farmakoökonómiai vonatkozásai.

Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakológiai Egyesület lapja = official journal of the Hungarian Association of Psychopharmacology

Volumn 7, Issue 4, 2005, Pages 199-207

  Bartkó, György ^a   Fehér, László ^a  

^a Pszichiátriai és Pszichiátriai Rehabilitációs Osztály   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT; RISPERIDONE;

COST BENEFIT ANALYSIS; DELAYED RELEASE FORMULATION; ECONOMICS; EUROPE; HOSPITAL READMISSION; HUMAN; HUNGARY; INTRAMUSCULAR DRUG ADMINISTRATION; PATIENT COMPLIANCE; PHARMACOECONOMICS; REVIEW; SCHIZOPHRENIA; UNITED STATES;

ANTIPSYCHOTIC AGENTS; COST-BENEFIT ANALYSIS; DELAYED-ACTION PREPARATIONS; ECONOMICS, PHARMACEUTICAL; EUROPE; HUMANS; HUNGARY; INJECTIONS, INTRAMUSCULAR; PATIENT COMPLIANCE; PATIENT READMISSION; RISPERIDONE; SCHIZOPHRENIA; UNITED STATES;

EID: 33645223884     PISSN: 14198711     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)